THCz: Small molecules with antimicrobial activity that block cell wall lipid intermediatesVisa övriga samt affilieringar
2021 (Engelska)Ingår i: Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, E-ISSN 1091-6490, Vol. 118, nr 47, artikel-id e2108244118Artikel i tidskrift (Refereegranskat) Published
Abstract [en]
Emerging antibiotic resistance demands identification of novel antibacterial compound classes. A bacterial whole-cell screen based on pneumococcal autolysin-mediated lysis induction was developed to identify potential bacterial cell wall synthesis inhibitors. A hit class comprising a 1-amino substituted tetrahydrocarbazole (THCz) scaffold, containing two essential amine groups, displayed bactericidal activity against a broad range of gram-positive and selected gram-negative pathogens in the low micromolar range. Mode of action studies revealed that THCz inhibit cell envelope synthesis by targeting undecaprenyl pyrophosphate-containing lipid intermediates and thus simultaneously inhibit peptidoglycan, teichoic acid, and polysaccharide capsule biosynthesis. Resistance did not readily develop in vitro, and the ease of synthesizing and modifying these small molecules, as compared to natural lipid II-binding antibiotics, makes THCz promising scaffolds for development of cell wall-targeting antimicrobials.
Ort, förlag, år, upplaga, sidor
National Academy of Sciences of the United States of America , 2021. Vol. 118, nr 47, artikel-id e2108244118
Nyckelord [en]
Streptococcus pneumoniae, antibiotic resistance, antimicrobials, cell wall biosynthesis, tetrahydrocarbazole
Nationell ämneskategori
Mikrobiologi Mikrobiologi inom det medicinska området
Identifikatorer
URN: urn:nbn:se:umu:diva-191611DOI: 10.1073/pnas.2108244118ISI: 000723039000018PubMedID: 34785593Scopus ID: 2-s2.0-85121274127OAI: oai:DiVA.org:umu-191611DiVA, id: diva2:1630475
Forskningsfinansiär
Stiftelsen för strategisk forskning (SSF)VetenskapsrådetKnut och Alice Wallenbergs StiftelseRegion StockholmGöran Gustafssons stiftelse för naturvetenskaplig och medicinsk forskning (KVA)2022-01-202022-01-202022-01-20Bibliografiskt granskad